Patient Dedicated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Amicus Therapeutics (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, announced that it has entered into a definitive agreement for a $430 million financing collaboration with funds managed by Blackstone (NYSE: BX). As part of the collaboration, Blackstone Life Sciences and Blackstone Credit have agreed to provide Amicus with a $400 million senior secured term loan facilitating a refinancin...

NYU Langone Health Performs World's First Successful Face and Double Hand Transplant USA - English News provided by Share this article Share this article NEW YORK, Feb. 3, 2021 /PRNewswire/ -- A surgical team from NYU Langone Health performed a face and double hand transplant for a 22-year-old New Jersey resident severely burned in a horrific car crash. The surgery included transplanting both hands and the full face of a single donor. It marked the first successful combination transplant case of its kind in the world. A 22-year-old from New Jersey has received the world’s first successful...